| Representative coexpressed gene network |

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| hsa05133 |
Pertussis |
41 |
 |
| hsa05417 |
Lipid and atherosclerosis |
23 |
 |
| hsa05171 |
Coronavirus disease - COVID-19 |
21 |
 |
| hsa05152 |
Tuberculosis |
19 |
 |
| hsa05142 |
Chagas disease |
19 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mmu05133 |
Pertussis |
47 |
 |
| mmu05417 |
Lipid and atherosclerosis |
33 |
 |
| mmu05171 |
Coronavirus disease - COVID-19 |
27 |
 |
| mmu05152 |
Tuberculosis |
26 |
 |
| mmu04625 |
C-type lectin receptor signaling pathway |
25 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| rno05133 |
Pertussis |
44 |
 |
| rno05417 |
Lipid and atherosclerosis |
23 |
 |
| rno05171 |
Coronavirus disease - COVID-19 |
22 |
 |
| rno04936 |
Alcoholic liver disease |
20 |
 |
| rno05152 |
Tuberculosis |
20 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mcc05133 |
Pertussis |
41 |
 |
| mcc05171 |
Coronavirus disease - COVID-19 |
25 |
 |
| mcc05142 |
Chagas disease |
20 |
 |
| mcc05417 |
Lipid and atherosclerosis |
20 |
 |
| mcc05135 |
Yersinia infection |
18 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| cfa05133 |
Pertussis |
38 |
 |
| cfa05171 |
Coronavirus disease - COVID-19 |
20 |
 |
| cfa05417 |
Lipid and atherosclerosis |
20 |
 |
| cfa05142 |
Chagas disease |
18 |
 |
| cfa05200 |
Pathways in cancer |
18 |
 |
|

| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| fca05133 |
Pertussis |
35 |
 |
| fca05171 |
Coronavirus disease - COVID-19 |
23 |
 |
| fca05142 |
Chagas disease |
19 |
 |
| fca05152 |
Tuberculosis |
18 |
 |
| fca05417 |
Lipid and atherosclerosis |
18 |
 |
|
| Gene list in the network |
|
|
Symbol |
Function* |
| |
Actb |
actin, beta |
| |
Aif1 |
allograft inflammatory factor 1 |
| |
Rhoa |
ras homolog family member A |
| |
Atf3 |
activating transcription factor 3 |
| |
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
| |
C1qa |
complement component 1, q subcomponent, alpha polypeptide |
| |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
| |
C1qc |
complement component 1, q subcomponent, C chain |
| |
C2 |
complement component 2 (within H-2S) |
| |
C3 |
complement component 3 |
| |
C4b |
complement component 4B (Chido blood group) |
| |
Calm1 |
calmodulin 1 |
| |
Calm2 |
calmodulin 2 |
| |
Calm3 |
calmodulin 3 |
| |
Casp1 |
caspase 1 |
| |
Casp12 |
caspase 12 |
| |
Cd14 |
CD14 antigen |
| |
Cfl1 |
cofilin 1, non-muscle |
| |
Cfl2 |
cofilin 2, muscle |
| |
Cp |
ceruloplasmin |
| |
Csf1r |
colony stimulating factor 1 receptor |
| |
Csf3 |
colony stimulating factor 3 (granulocyte) |
| |
Adgre1 |
adhesion G protein-coupled receptor E1 |
| |
Fos |
FBJ osteosarcoma oncogene |
| |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
| |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
| |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
| |
Cfb |
complement factor B |
| |
Hpse |
heparanase |
| |
Irf8 |
interferon regulatory factor 8 |
| |
Il1a |
interleukin 1 alpha |
| |
Il1b |
interleukin 1 beta |
| |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
| |
Il6 |
interleukin 6 |
| |
Irf1 |
interferon regulatory factor 1 |
| |
Itgam |
integrin alpha M |
| |
Itgb2 |
integrin beta 2 |
| |
Jun |
jun proto-oncogene |
| |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
| |
Ly96 |
lymphocyte antigen 96 |
| |
Mertk |
MER proto-oncogene tyrosine kinase |
| |
Ncf1 |
neutrophil cytosolic factor 1 |
| |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
| |
Nfkb2 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
| |
Osm |
oncostatin M |
| |
Pfn1 |
profilin 1 |
| |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) |
| |
Mapk11 |
mitogen-activated protein kinase 11 |
| |
Dusp1 |
dual specificity phosphatase 1 |
| |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
| |
Ccl3 |
chemokine (C-C motif) ligand 3 |
| |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
| |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
| |
Tlr4 |
toll-like receptor 4 |
| |
Tnf |
tumor necrosis factor |
| |
Mapk1 |
mitogen-activated protein kinase 1 |
| |
Mapk14 |
mitogen-activated protein kinase 14 |
| |
Mapk3 |
mitogen-activated protein kinase 3 |
| |
Mapk8 |
mitogen-activated protein kinase 8 |
| |
Mapk12 |
mitogen-activated protein kinase 12 |
| |
C1s1 |
complement component 1, s subcomponent 1 |
| |
C1ra |
complement component 1, r subcomponent A |
| |
Ptbp2 |
polypyrimidine tract binding protein 2 |
| |
Pycard |
PYD and CARD domain containing |
| |
Calml3 |
calmodulin-like 3 |
| |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
| |
Vsir |
V-set immunoregulatory receptor |
| |
Calm4 |
calmodulin 4 |
| |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
| |
Gpr84 |
G protein-coupled receptor 84 |
| |
Il23a |
interleukin 23, alpha subunit p19 |
| |
Pla1a |
phospholipase A1 member A |
| |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
| |
Hdac10 |
histone deacetylase 10 |
| |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
| |
Nlrp3 |
NLR family, pyrin domain containing 3 |
| |
Kcnk13 |
potassium channel, subfamily K, member 13 |
| |
Gm94 |
predicted gene 94 |
| |
Ticam2 |
toll-like receptor adaptor molecule 2 |
| |
C1rl |
complement component 1, r subcomponent-like |
| |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
| |
Gm14023 |
predicted gene 14023 |
|
|
|
|
|